Will psilocybin lose its magic in the clinical setting?
Therapeutic Advances in Psychopharmacology 2022 Caroline Hayes, Mourad Wahba, Stuart Watson 17 citations
Psilocybin as a novel treatment for depression is garnering a lot of attention from both the mainstream media and the academic community. Although phase 3 trials are only just beginning, we feel that it is important for clinicians to consider what psilocybin-assisted psychotherapy might look like in the clinical setting. In this narrative review article we have considered the difficulties that...